Swedish Orphan Biovitrum
International biopharmaceutical company focused on rare hematology, immunology and specialty-care diseases.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Haemophilia A (Moderate or Severe)
Pacritinib Effectiveness in Real-world SettingsNA · Recruiting · Myelofibrosis (MF)
Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog AlfaPhase 4 · Recruiting · Hemophilia A
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country StudyPhase 4 · Recruiting · C3 Glomerulopathy (C3G)
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)Phase 3 · Active Not Recruiting · Still's Disease, Juvenile Onset
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia MyelofibrosisPhase 3 · Active Not Recruiting · Primary Myelofibrosis
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/swedish-orphan-biovitrum/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.